Article By:
BioMedReports
Wednesday, November 5, 2014 9:59 AM EDT
Recent breakthroughs from Cell Source in Veto Cell technology, which selectively tunes immune response, may change how immunologists treat blood cancers and bone marrow transplants
In this article: CLCS